Cargando…

Comparison of the impact of autologous cell therapy and conservative standard treatment on tissue oxygen supply and course of the diabetic foot in patients with chronic limb-threatening ischemia: A randomized controlled trial

BACKGROUND: Autologous cell therapy (ACT) is a new treatment method for patients with diabetes and no-option chronic limb-threatening ischemia (NO-CLTI). We aimed to assess the impact of ACT on NO-CLTI in comparison with standard treatment (ST) in a randomized controlled trial. METHODS: Diabetic pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dubský, Michal, Husáková, Jitka, Bem, Robert, Jirkovská, Alexandra, Němcová, Andrea, Fejfarová, Vladimíra, Sutoris, Karol, Kahle, Michal, Jude, Edward B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464922/ https://www.ncbi.nlm.nih.gov/pubmed/36105404 http://dx.doi.org/10.3389/fendo.2022.888809

Ejemplares similares

Difference in Serum Endostatin Levels in Diabetic Patients with Critical Limb Ischemia Treated by Autologous Cell Therapy or Percutaneous Transluminal Angioplasty
por: Nemcova, Andrea, et al.
Publicado: (2018)

Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?
por: Dubský, Michal, et al.
Publicado: (2023)

The Superiority of Removable Contact Splints in the Healing of Diabetic Foot during Postoperative Care
por: Fejfarová, Vladimíra, et al.
Publicado: (2019)

Stimulation TcPO2 Testing Improves Diagnosis of Peripheral Arterial Disease in Patients With Diabetic Foot
por: Fejfarová, Vladimíra, et al.
Publicado: (2021)

Factors Influencing the Risk of Major Amputation in Patients with Diabetic Foot Ulcers Treated by Autologous Cell Therapy
por: Husakova, J., et al.
Publicado: (2022)

Role of Quantitative Bone Scanning in the Assessment of Bone Turnover in Patients With Charcot Foot
por: Bem, Robert, et al.
Publicado: (2010)

Effects of a 12-Week Interventional Exercise Programme on Muscle Strength, Mobility and Fitness in Patients With Diabetic Foot in Remission: Results From BIONEDIAN Randomised Controlled Trial
por: Vrátná, Eliška, et al.
Publicado: (2022)

Impact of Inherited Prothrombotic Disorders on the Long-Term Clinical Outcome of Percutaneous Transluminal Angioplasty in Patients with Diabetes
por: Dubský, Michal, et al.
Publicado: (2015)

Microdialysis as a tool for antibiotic assessment in patients with diabetic foot: a review
por: Fejfarová, Vladimíra, et al.
Publicado: (2023)

Comment on “Impact of Diabetic Foot on Selected Psychological or Social Characteristics”
por: Fejfarová, Vladimíra, et al.
Publicado: (2014)

The Effects of Immunosuppressive Drugs on the Characteristics and Functional Properties of Bone Marrow-Derived Stem Cells Isolated from Patients with Diabetes Mellitus and Peripheral Arterial Disease
por: Husakova, Jitka, et al.
Publicado: (2023)

An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens
por: Fejfarová, Vladimíra, et al.
Publicado: (2016)

Does the Diabetic Foot Have a Significant Impact on Selected Psychological or Social Characteristics of Patients with Diabetes Mellitus?
por: Fejfarová, Vladimíra, et al.
Publicado: (2014)

Endothelial Dysfunction in Diabetes Mellitus: New Insights
por: Dubsky, Michal, et al.
Publicado: (2023)

Results of a prospective observational study of autologous peripheral blood mononuclear cell therapy for no-option critical limb-threatening ischemia and severe diabetic foot ulcers
por: Panunzi, Andrea, et al.
Publicado: (2022)

Autologous Peripheral Blood Mononuclear Cells for Limb Salvage in Diabetic Foot Patients with No-Option Critical Limb Ischemia
por: Scatena, Alessia, et al.
Publicado: (2021)

Chronic Limb-Threatening Ischemia and the Need for Revascularization
por: Berchiolli, Raffaella, et al.
Publicado: (2023)

Association of wound, ischemia, and foot infection clinical stage with frailty and malnutrition in chronic limb-threatening ischemia patients undergoing endovascular intervention
por: Otsuji, Hideaki, et al.
Publicado: (2022)

A misplaced intramuscular injection and limb-threatening ischemia
por: Sarkar, Sumantra, et al.
Publicado: (2017)

The Impact of Chronic Limb-Threatening Ischemia on Cardiac Surgery
por: Wakabayashi, Naohiro, et al.
Publicado: (2022)

MicroRNA Profile of Patients with Chronic Limb-Threatening Ischemia
por: Syed, Muzammil H., et al.
Publicado: (2020)

Therapeutic Biomaterial Approaches to Alleviate Chronic Limb Threatening Ischemia
por: Marsico, Grazia, et al.
Publicado: (2021)

Stakeholder Values and Preferences in Lower Limb Amputation for No-Option Chronic Limb Threatening Ischemia
por: Nieuwstraten, Jelle A, et al.
Publicado: (2021)

Unheralded Lower limb threatening ischemia in a COVID-19 patient
por: Vacirca, Andrea, et al.
Publicado: (2020)

Gene Therapy of Chronic Limb-Threatening Ischemia: Vascular Medical Perspectives
por: Simon, Florian, et al.
Publicado: (2022)

Unique Metabolomic Profile of Skeletal Muscle in Chronic Limb Threatening Ischemia
por: Khattri, Ram B., et al.
Publicado: (2021)

Pain Management in People with Diabetes-Related Chronic Limb-Threatening Ischemia
por: Jiang, Xiaoyan, et al.
Publicado: (2021)

Critical Determinants of Chronic Limb Threatening Ischemia After Endovascular Treatment
por: Kim, Wonho
Publicado: (2022)

Comparison of arterial and venous allograft bypass in chronic limb-threatening ischemia
por: Garbaisz, Dávid, et al.
Publicado: (2022)

Influence of the COVID-19 pandemic on the management of chronic limb-threatening ischemia
por: Miranda, Jorge A., et al.
Publicado: (2021)

Case planning and execution of inframalleolar bypass for chronic limb-threatening ischemia
por: Gomez-Sanchez, Clara M., et al.
Publicado: (2023)

Sarcopenia as a Possible Negative Predictor of Limb Salvage in Patients with Chronic Limb-Threatening Ischemia
por: Taniguchi, Ryosuke, et al.
Publicado: (2019)

Effects of PCSK9 Inhibitor on Favorable Limb Outcomes in Patients with Chronic Limb-Threatening Ischemia
por: Sato, Yusuke, et al.
Publicado: (2021)

Fibronectin in hyperglycaemia and its potential use in the treatment of diabetic foot ulcers: A review
por: Kanta, Jiri, et al.
Publicado: (2022)

Improving Limb Salvage for Chronic Limb-Threatening Ischemia With Spinal Cord Stimulation: A Retrospective Analysis
por: Cyrek, Anna E., et al.
Publicado: (2021)

Cell Therapy for Chronic Limb‐Threatening Ischemia: Current Evidence and Future Directions
por: Teraa, Martin, et al.
Publicado: (2018)

Applicability of Transcutaneous Oxygen Tension Measurement in the Assessment of Chronic Limb-Threatening Ischemia
por: Leenstra, Bernard, et al.
Publicado: (2019)

Prevalence of elevated serum fatty acid synthase in chronic limb-threatening ischemia
por: Tay, Shirli, et al.
Publicado: (2021)

The catastrophic impact of COVID-19 infection in patients with chronic limb-threatening ischemia
por: de Athayde Soares, Rafael, et al.
Publicado: (2022)

The Inflammatory Pattern of Chronic Limb-Threatening Ischemia in Muscles: The TNF-α Hypothesis
por: Caicedo, Diego, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bj2lmgq6dkgsptpi3qko01ptrf